Cervical cancer screening of women living with HIV infection: A must in the Era of antiretroviral therapy

Clinical Infectious Diseases

Volumn 45, Issue 4, 2007, Pages 510-513

  Franceschi, Silvia ^a   Jaffe, Harold ^b  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

AFRICA; CANCER SCREENING; FEMALE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE NEED; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LIFE EXPECTANCY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; UTERINE CERVIX CANCER; WART VIRUS;

ANTI-RETROVIRAL AGENTS; FEMALE; HIV INFECTIONS; HUMANS; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 34547632731     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520022     Document Type: Review

References (29)

1. United Nations Programme on AIDS (UNAIDS)/World Health Organization (WHO). AIDS epidemic update: December 2006. Geneva: UNAIDS/WHO, 2006.
2. Franceschi S, Herrero R, Clifford GM, et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int J Cancer 2006; 119:2677-84.
3. Parkin DM, Ferlay J, Hamdi-Cherif M, et al. Cervix cancer: In: Cancer in Africa: epidemiology and prevention. Lyon, France: IARC Press, 2003:268-76.
4. Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S. Trends in cancer incidence in Kyadondo County, Uganda, 1960-1997. Br J Cancer 2000; 82:1585-92.
5. Strickler HD, Burk RD, Fazzari M, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 2005; 97:577-86.
6. Clifford GM, Gonçalves MA, Franceschi S. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS 2006; 20:2337-44.
7. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000; 92:1500-10.
8. Dal Maso L, Franceschi S, Polesel J, et al. Risk of cancer in persons with AIDS in Italy, 1985-1998. Br J Cancer 2003; 89:94-100.
9. Mbulaiteye SM, Katabira ET, Wabinga H, et al. Spectrum of cancers among HIV-infected persons in Africa: The Uganda AIDS-Cancer Registry Match Study. Int J Cancer 2006; 118: 985-90.
10. International Agency for Research on Cancer (IARC). IARC handbooks of cancer prevention, volume 10: cervix cancer screening. Lyon, France: IARC Press, 2005.
11. Stein MD, Cunningham WE, Nakazono T, et al. Screening for cervical cancer in HIV-infected women receiving care in the United States. J Acquir Immune Defic Syndr 2001; 27:463-6.
12. Cubie HA, Seagar AL, Beattie GJ, Monaghan S, Williams AR. A longitudinal study of HPV detection and cervical pathology in HIV-infected women. Sex Transm Infect 2000; 76: 257-61.
13. Serraino D, Dal Maso L, La Vecchia C, Franceschi S. Invasive cervical cancer as an AIDS-defining illness in Europe. AIDS 2002; 16: 781-6.
14. Franceschi S, Dal Maso L, Suligoi B, Rezza G. Evidence for lack of cervical cancer screening among HIV-positive women in Italy. Eur J Cancer Prev 2006; 15:554-56.
15. Mayans MV, Maguire A, Miret M, Casabona J. Disproportionate high incidence of invasive cervical cancer as an AIDS-indicative disease among young women in Catalonia, Spain. Sex Transm Dis 1999; 26:500-03.
16. Galceran J, Marcos-Gragera R, Soler M, et al. Cancer incidence in AIDS patients in Catalonia, Spain. Eur J Cancer 2007; 43:1085-91.
17. Murri R, Franceschi S, Ravizza M, et al. Access to gynecological services and Papanicolau tests in HIV-infected Italian women: a questionnaire survey. AIDS Care 2006; 18:376-8.
18. United Nations Programme on AIDS/World Health Organization. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report, April 2007. Geneva: World Health Organization, 2007.
19. Franceschi S, Dal Maso L, Pezzotti P, et al. Incidence of AIDS-defining cancers after AIDS diagnosis among people with AIDS in Italy, 1986-1998. J Acquir Immune Defic Syndr 2003; 34:84-90.
20. Engels EA, Pfeiffer RM, Goedert JJ, et al. Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS 2006; 20:1645-54.
21. Heard I, Palefsky JM, Kazatchkine MD. The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases. Antivir Ther 2004; 9:13-22.
22. The US President's Emergency Plan for AIDS Relief (PEPFAR). Available at: http://www .pepfar.gov. Accessed December 2006.
23. Gilks CF, Crowley S, Ekpini R, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 2006; 368:505-10.
24. Almonte M, Ferreccio C, Winkler JL, et al. Cervical screening by visual inspection, HPV testing, liquid-based and conventional cytology in Amazonian Peru. Int J Cancer 2007; 121:796-802.
25. Lorincz AT. HPV testing by hybrid capture. In: Monsonego J, ed. Emerging issues of HPV infections: from science to practice. Basel, Switzerland: Karger, 2006:54-62.
26. Parham GP, Sahasrabuddhe W, Mwanahamuntu MH, et al. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol 2006; 103:1017-22.
27. Goldie SJ, Weinstein MC, Kuntz KM, Freedberg KA. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women. Ann Intern Med 1999; 130:97-107.
28. Saslow D, Castle PE, Cox JT, et al. American Cancer Society guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin 2007; 57:7-28.
29. Palefsky JM, Gillison ML, Strickler HD. Chapter 16: HPV vaccines in immunocompromised women and men. Vaccine 2006; 24(Suppl 3): S140-6.